BLDV was stuck in mid trips the first 19 days of Q2. Then on 4/20 Alper published his infamous PR announcing a partnership with AMS who --he proclaimed-- was in the "final stage of licensing." People obviously read that to mean that AMS was very close to starting production. That set off a buying binge that topped off at .0057.
Only later did people learn that AMS needed an infusion of $12 million --and many more months after funding was secured-- before any licensing and growing would commence.
In the mean time, a lot of money presumably flowed into AMS. It will be interesting to see how Alper used it.